StonvexLoading…
StonvexCore line items from SSP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.15B | $2.51B | $2.29B | $2.45B |
Operating Income | $183.99M | $412.49M | $-753.24M | $428.34M |
Net Income | $-100.88M | $146.22M | $-947.78M | $195.90M |
EPS (Diluted) | $-1.87 | $1.01 | $-11.84 | $1.62 |
Total Assets | $5.01B | $5.20B | $5.41B | $6.43B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $27.92M | $23.85M | $35.32M | $18.03M |
Free Cash Flow OCF − CapEx | $6.52M | $300.42M | $51.98M | $265.63M |
Shares Outstanding | 88.02M | 86.07M | 84.27M | 87.35M |